SEARCH

SEARCH BY CITATION

References

  • 1
    Schiffman M, Kjaer SK. Chapter 2: natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 2003; 31: 149.
  • 2
    Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 7196.
  • 3
    Castle PE, Schiffman M, Bratti MC, Hildesheim A, Herrero R, Hutchinson ML, Rodriguez AC, Wacholder S, Sherman ME, Kendall H, Viscidi RP, Jeronimo J, et al. A population-based study of vaginal human papillomavirus infection in hysterectomized women. J Infect Dis 2004; 190: 45867.
  • 4
    Castle PE, Rodriguez AC, Porras C, Herrero R, Schiffman M, Gonzalez P, Hildesheim A, Burk RD. A comparison of cervical and vaginal human papillomavirus. Sex Transm Dis 2007; 34: 84955.
  • 5
    Castle PE, Schiffman M, Glass AG, Rush BB, Scott DR, Wacholder S, Dunn A, Burk RD. Human papillomavirus prevalence in women who have and have not undergone hysterectomies. J Infect Dis 2006; 194: 17025.
  • 6
    Winer RL, Hughes JP, Feng Q, O'Reilly S, Kiviat NB, Koutsky LA. Comparison of incident cervical and vulvar/vaginal human papillomavirus infections in newly sexually active young women J Infect Dis 2009; 199: 81518.
  • 7
    Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007; 370: 5967.
  • 8
    Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, Young M, Greenblatt R, Sacks H, Feldman J. The women's interagency HIV study. WIHS collaborative study group. Epidemiology 1998; 9: 11725.
  • 9
    Bacon MC, von Wyl V, Alden C, Sharp G, Robison E, Hessol N, Gange S, Barranday Y, Holman S, Weber K, Young MA. The women's interagency HIV study: an observational cohort brings clinical sciences to the bench Clin Diagn Lab Immunol 2005; 12: 101319.
  • 10
    Minkoff H, Feldman J, DeHovitz J, Landesman S, Burk R. A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. Am J Obstet Gynecol 1998; 178: 9826.
  • 11
    Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Jr, Young N, Forum Group Members, et al. The 2001 bethesda system: terminology for reporting results of cervical cytology. JAMA 2002; 287: 211419.
  • 12
    Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, Hall C, Bacon M, Levine AM, Watts DH, Silverberg MJ, Xue X, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 2005; 97: 57786.
  • 13
    Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS, Burk RD. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems J Clin Microbiol 1997; 35: 130410.
  • 14
    Jiang G, Qu W, Ruan H, Burk RD. Elimination of false-positive signals in enhanced chemiluminescence (ECL) detection of amplified HPV DNA from clinical samples. BioTechniques 1995; 19: 56668.
  • 15
    Castle PE, Schiffman M, Gravitt PE, Kendall H, Fishman S, Dong H, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Lorincz A, Schussler JE, et al. Comparisons of HPV DNA detection by MY09/11 PCR methods. J Med Virol 2002; 68: 41723.
  • 16
    Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, WHO International Agency for Research on Cancer. Carcinogenicity of human papillomaviruses. Lancet Oncol 2005; 6: 204.
  • 17
    Schiffman M, Clifford G, Buonaguro FM. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer 2009; 4: 8.
  • 18
    Xue X, Gange SJ, Zhong Y, Burk RD, Minkoff H, Massad LS, Watts DH, Kuniholm MH, Anastos K, Levine AM, Fazzari M, D'Souza G, et al. Marginal and mixed-effects models in the analysis of human papillomavirus natural history data. Cancer Epidemiol Biomarkers Prev 2010; 19: 15969.
  • 19
    Jamieson DJ, Paramsothy P, Cu-Uvin S, Duerr A, HIV Epidemiology Research Study G. Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus Obstet Gynecol 2006; 107: 102328.
  • 20
    Massad LS, Seaberg EC, Wright RL, Darragh T, Lee YC, Colie C, Burk R, Strickler HD, Watts DH. Squamous cervical lesions in women with human immunodeficiency virus: long-term follow-up Obstet Gynecol 2008; 111: 138893.
  • 21
    Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, Grigg R, Hylton T, Pawlish KS, McNeel TS, Goedert JJ. Cancer risk in people infected with human immunodeficiency virus in the united states. Int J Cancer 2008; 123: 18794.
  • 22
    Chaturvedi AK, Madeleine MM, Biggar R.J. Engels EA. Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst 2009; 101: 112030.
  • 23
    ACOG Committee on Practice Bulletins—Gynecology. ACOG practice bulletin no. 109: cervical cytology screening Obstet Gynecol 2009; 114: 140920.